Danish biotech startup EvodiaBio secures €6 million in funding to expand its yeast-based natural flavor production into Asian markets.
Information on the Target
Copenhagen-based EvodiaBio is an innovative biotech startup founded in 2021 by Jarne Elleholm and Sotirios Kampranis. The company specializes in producing natural flavors through yeast-based fermentation. By employing precision fermentation techniques, EvodiaBio successfully generates monoterpenes, which are volatile aroma compounds commonly found in hops and other plants.
Utilizing its proprietary platform, Yops®, the company can achieve industrial-scale production of specific natural aromas. This sophisticated method not only mitigates dependence on harvested plants but also significantly reduces environmental impact while delivering customizable and consistent flavor profiles for use in beverages, food, and various other products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
Denmark has emerging as a prominent hub for biotech innovation, especially in sectors focused on sustainable production and environmental solutions. The Danish government has been supportive of the biotech industry, prov
Similar Deals
DanBAN investors → LifeBoard ApS
2023
Danish Business Angels and Vækstfonden → Knowledge Gate Group
2023
RA Capital Management’s Planetary Health Fund
invested in
EvodiaBio
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $6M